AFX.DE Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 апр. 2024 @ 12:09):

Stats
Объем за сегодня	6 610.00
Средний объем	131 971
Рыночная капитализация	9.02B
EPS	€0 ( 2024-02-09 )
Дата следующего отчета о доходах	( €0.880 ) 2024-05-07
Last Dividend	€1.100 ( 2023-03-23 )
Next Dividend	€0 ( N/A )
P/E	32.52
ATR14	€0.116 (0.12%)

Объем Корреляция

Длинно: -0.02 (neutral)

Кратко: -0.08 (neutral)

Signal:(49.849) Neutral

Carl Zeiss Meditec AG Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Carl Zeiss Meditec AG Корреляция - Валюта/Сырье

-0.62
( weak negative )

-0.50
( weak negative )

0.00
( neutral )

-0.32
( neutral )

-0.14
( neutral )

0.61
( weak )

Carl Zeiss Meditec AG Финансовые показатели

Annual	2023
Выручка:	€2.09B
Валовая прибыль:	€1.21B (57.71 %)
EPS:	€3.25

FY	2023
Выручка:	€2.09B
Валовая прибыль:	€1.21B (57.71 %)
EPS:	€3.25

FY	2022
Выручка:	€1.90B
Валовая прибыль:	€1.13B (59.26 %)
EPS:	€3.29

FY	2021
Выручка:	€1.65B
Валовая прибыль:	€967.21M (58.73 %)
EPS:	€2.64

Financial Reports:

No articles found.

Carl Zeiss Meditec AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€1.100 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Carl Zeiss Meditec AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.69 - low (22.66%) | Divividend Growth Potential Score: 4.66 - Stable (6.90%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.117	2006-03-13
Last Dividend	€1.100	2023-03-23
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	€8.36	--
Avg. Dividend % Per Year	0.00%	--
Score	1.94	--
Div. Sustainability Score	3.69
Div.Growth Potential Score	4.66
Div. Directional Score	4.17	--

Next Divdend (Est)
(2024-12-17)

€0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
VVD.DE	Ex Dividend Knight	2023-05-09	Annually	0.00%
EVK.DE	Ex Dividend Junior	2023-06-01	Annually	0.00%
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0.00%
AMG.DE	Ex Dividend Knight	2023-08-17	Quarterly	0.00%
HAW.DE	Ex Dividend Junior	2023-06-13	Annually	0.00%
RIO1.DE	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
BST.DE	Ex Dividend Junior	2023-09-14	Sporadic	0.00%
JNJ.DE	Ex Dividend Knight	2023-08-25	Quarterly	0.00%
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
DEF.DE	Ex Dividend Knight	2023-07-24	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.132	1.500	7.36	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.134	1.500	9.62	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	24.02	1.000	2.22	2.22	[3 - 30]
operatingCashFlowPerShareTTM	2.62	2.00	9.13	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.345	2.00	9.33	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.573	1.000	3.78	3.78	[0.2 - 0.8]
operatingProfitMarginTTM	0.196	1.000	8.08	8.08	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	32.27	1.000	6.84	0	[1 - 100]
returnOnEquityTTM	0.134	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.345	2.00	9.55	10.00	[0 - 30]
dividendYielPercentageTTM	1.097	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.62	2.00	9.13	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-3.17	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.112	1.000	9.71	0	[0.1 - 0.5]
Total Score				4.66

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.